Apollo Endosurgery to Present at November Investor Conferences

Rhea-AI Summary

Austin, TX / Accesswire / November 3, 2020 / Apollo Endosurgery, Inc. (NASDAQ:APEN) announced participation in two investor conferences in November 2020. On November 17, they will engage in one-on-one meetings at the Craig Hallum Alpha Select Investor Conference. Following this, on November 19, they will present at the Sidoti Virtual Microcap Conference 2020 and conduct additional one-on-one meetings. Apollo specializes in less invasive medical devices for gastrointestinal and bariatric procedures, serving over 75 countries with advanced therapeutic options.

AUSTIN, TX / ACCESSWIRE / November 3, 2020 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announced that its management team will participate in two upcoming investor conference events during November 2020.

November 17, 2020

Craig Hallum Alpha Select Investor Conference

Apollo will participate in one on one meetings throughout the day.

November 19, 2020

Sidoti Virtual Microcap Conference 2020

Apollo will provide a group presentation and host one on one meetings throughout the day.

Investors interested in attending the virtual presentation or arranging meetings should contact their respective conference host representative or Apollo's investor relations, Matt Kreps of Darrow Associates, mkreps@darrowir.com.

About Apollo Endosurgery, Inc.

Apollo Endosurgery, Inc. is a medical technology company focused on less invasive therapies to treat various gastrointestinal conditions, ranging from gastrointestinal complications to the treatment of obesity. Apollo's device-based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo's products are offered in over 75 countries today and include the OverStitch™ Endoscopic Suturing System, the OverStitch Sx™ Endoscopic Suturing System, and the ORBERA® Intragastric Balloon.

Apollo's common stock is traded on the Nasdaq Global Market under the symbol "APEN". For more information regarding Apollo Endosurgery, go to: www.apolloendo.com.

Contacts:

Apollo Endosurgery, Inc.
Stefanie Cavanaugh, 512-279-5100
investor-relations@apolloendo.com

Darrow Associates Investor Relations
Matt Kreps, 214-597-8200
mkreps@darrowir.com

SOURCE: Apollo Endosurgery, Inc.

View source version on accesswire.com:
https://www.accesswire.com/614115/Apollo-Endosurgery-to-Present-at-November-Investor-Conferences

FAQ

When will Apollo Endosurgery present at investor conferences?

Apollo Endosurgery will present at the Craig Hallum Alpha Select Investor Conference on November 17, 2020, and at the Sidoti Virtual Microcap Conference on November 19, 2020.

What is the significance of the November 2020 conferences for Apollo Endosurgery?

The November 2020 conferences provide Apollo Endosurgery an opportunity for investor engagement through presentations and one-on-one meetings, highlighting their innovative medical devices.

What does Apollo Endosurgery specialize in?

Apollo Endosurgery specializes in less invasive medical devices aimed at treating gastrointestinal and bariatric conditions.

How can investors attend Apollo Endosurgery's virtual presentations?

Investors interested in attending the virtual presentations or arranging meetings should contact the respective conference host or Apollo's investor relations.

What are some products offered by Apollo Endosurgery?

Apollo Endosurgery offers products like the OverStitch™ Endoscopic Suturing System, OverStitch Sx™, and ORBERA® Intragastric Balloon.